期刊文献+

血沉、HLA-B27基因、C反应蛋白测定对强直性脊柱炎的诊断价值 被引量:20

Diagnostic value of ESR, HLA - B27 genes, CRP for ankylosing spondylitis
下载PDF
导出
摘要 目的血沉、HLA-B27基因、C反应蛋白测定对强直性脊柱炎的诊断价值。方法采用Westergren法、免疫浊度分析法及流式细胞分析,分别检测AS患者(60例)健康体检者(30例)的血沉(ESR)、C反应蛋白(C-re-active protein,CRP)、HLA-B27,并进行统计学分析。结果 AS组疾病活动情况、ESR、CRP水平、HLA-B27阳性率及X线片改变率均高于对照组,差异有高度统计学意义(P<0.01)。ESR、CRP水平与AS的发生密切相关(P=0.008,P=0.009)。结论 ESR、CRP水平变化与AS病情活动有关,可以作为监控病情的反应指标;检测HLA-B27阳性并不能作为AS的确诊指标;降低强直性脊柱炎的炎性反应,可能有助于改善AS患者病情。 Objective To explore the diagnostic value of ESR, HLA-B27 genes, CRP for AS. Methods The Westergren method, immune turbidity analysis and flow cytometry analysis were used to detect the ESR, CRP level and HLA -B27 in AS patients (n = 60) and the healthy check-up (n =30), respectively, and the statistical analysis were dQne. Results AS group of disease activity, ESR, CRP levels, the positive rate of HLA-B27 and changes of X ray were high- er than those in the control group with significant difference (P 〈 0.01). The ESR and CRP levels were eloae!y related with the incidence of AS (P = 0,008, P = 0.008), Conclusion Chm^ges of ESR and CRP levels associates with AS disease activity, and can be used as a monitoring condition of reaction indicator; detecting the positive rate of HLA-B27 can not be the diagnosis index; reducing the inflammation of ankylosing spondylitis may help to improve AS patients" condition.
出处 《中国医药导报》 CAS 2013年第14期98-100,共3页 China Medical Herald
关键词 强直性脊柱炎 血沉 C反应蛋白 HLA—B27 诊断价值 Ankylosing spondylitis ESR CRP HLA-B27 Diagnostic value
  • 相关文献

参考文献15

二级参考文献49

  • 1褚洪涛,张百安.云克与松梅乐治疗强直性脊柱炎疗效对比观察[J].中国误诊学杂志,2004,4(3):418-419. 被引量:19
  • 2杨春花,黄烽.高敏C反应蛋白研究进展[J].中华风湿病学杂志,2004,8(12):755-758. 被引量:20
  • 3[2]Van der lieden SJ,Valkenburg HA,Cats A.Evaluation Of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the NewYork criteria[J].Arthritis Rheum,1984,27 (3):361-364.
  • 4Taylor HG,Wardle T,Beswick EJ, et al. The relationship of clinical and laboratory measurements to radiological change in AS. Br J Rheumatol, 1991,30:330-335.
  • 5Ruof J, Stucld G. Validity aspects of erythrocyte ,sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol, 1999,26 (4) : 966-970.
  • 6Van der Linden SJ, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum, 1984, 27: 361-368.
  • 7Cowling P, Ebringer R,Cawdell D, et al. C-reactive protein, ESR,and Klebsiella in ankylosing spondylitis. Ann Rheum Dis, 1980,39: 45-49.
  • 8Garrett SL,Jenkinson TR, Whitelock HC, et al. A new approach to defining disease status in ankylusing spondylitis: the Bath ankylosing spondylitis disease activity index (IAASDAI). J Rheumatol,1994,21 : 2286-2291.
  • 9Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte .sedimentation rate in patients with rheumatoid arthritis. J Rhetarmtol, 1997,24:1477-1485.
  • 10Spoorenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol,1999,26(4) :980-984.

共引文献57

同被引文献227

引证文献20

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部